Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Cyclosporin A inhibits the decrease of CD4/CD8 expression induced by protein kinase C activation

K Nakayama1, H Nakauchi

  • 1Laboratory of Molecular Regulation of Aging, Institute of Physical and Chemical Research (RIKEN), Ibaraki, Japan.

International Immunology
|April 1, 1993
PubMed
Summary

Cyclosporin A (CsA) inhibits T cell maturation by blocking protein kinase C (PKC) activation, which is essential for down-regulating CD4 and CD8 expression during thymocyte differentiation.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Diamond Blackfan anemia is mediated by hyperactive Nemo-like kinase.

Nature communications·2020
Same author

Inhibition of plasmin attenuates murine acute graft-versus-host disease mortality by suppressing the matrix metalloproteinase-9-dependent inflammatory cytokine storm and effector cell trafficking.

Leukemia·2014
Same author

Impaired hematopoietic differentiation of RUNX1-mutated induced pluripotent stem cells derived from FPD/AML patients.

Leukemia·2014
Same author

Haploinsufficiency of Sf3b1 leads to compromised stem cell function but not to myelodysplasia.

Leukemia·2014
Same author

Highly efficient generation of definitive endoderm lineage from human induced pluripotent stem cells.

Transplantation proceedings·2012
Same author

Plasmin inhibitor reduces T-cell lymphoid tumor growth by suppressing matrix metalloproteinase-9-dependent CD11b(+)/F4/80(+) myeloid cell recruitment.

Leukemia·2011

Area of Science:

  • Immunology
  • Cell Biology
  • Molecular Biology

Background:

  • Cyclosporin A (CsA) is a vital immunosuppressant in transplantation.
  • CsA inhibits the differentiation of double-positive (DP) CD4+ CD8+ thymocytes into single-positive (SP) T cells.
  • The precise mechanisms of CsA's interference with thymocyte maturation remain unclear.

Purpose of the Study:

  • To investigate the role of protein kinase C (PKC) in thymocyte differentiation.
  • To elucidate how CsA affects CD4 and CD8 expression during T cell development.
  • To understand the molecular basis of CsA's immunosuppressive effects on thymocyte maturation.

Main Methods:

  • Activation of PKC using phorbol 12-myristate 13-acetate (PMA) in T cell lines and thymocytes.
  • Treatment with a PKC inhibitor (staurosporine) in fetal thymus organ cultures.

Related Experiment Videos

  • Analysis of CD4 and CD8 surface expression and mRNA levels.
  • Assessment of CsA's effect on PMA-induced CD4/CD8 downregulation.
  • Investigation of cycloheximide's impact on PMA-induced changes.

    • Main Results:

    • PKC activation by PMA reduces CD4 and CD8 expression at both protein and mRNA levels.
    • PKC inhibition by staurosporine disrupts DP to SP thymocyte differentiation.
    • CsA prevents PMA-induced CD4/CD8 downregulation in vitro.
    • The PMA-induced reduction in CD4/CD8 expression requires new protein synthesis.
    • CsA blocks this de novo protein synthesis pathway.

    Conclusions:

    • PKC activation is critical for the downregulation of CD4/CD8 expression during thymocyte differentiation.
    • CsA interferes with thymocyte maturation by inhibiting PKC-mediated CD4/CD8 downregulation.
    • This inhibition likely involves blocking the synthesis of proteins induced by PKC signaling.